{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:44:28Z","timestamp":1792827868073,"version":"4.5.0"},"reference-count":81,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Lyme disease is an important, vector-borne infection found throughout the temperate Northern hemisphere. The disease causes rash, acute systemic illness, and in some untreated patients, inflammatory arthritis. This review examines the emergence, clinical features and management of early Lyme disease and Lyme arthritis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>There has been continuing progress in characterizing the clinical manifestations, diagnostic testing and treatment of Lyme disease. Almost all patients with early Lyme disease can be cured with antibiotic treatment. In most cases, Lyme arthritis also responds to antibiotics, but some patients require additional treatment approaches.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>The diagnosis of Lyme disease is based on clinical manifestations and adjunctive laboratory testing. For the rheumatologist, Lyme arthritis should be recognized by a pattern of attacks of asymmetric, oligo-arthritis, recognizable by clinical manifestations in the same way that other rheumatic diseases, such as gout or rheumatoid arthritis, are diagnosed.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000698","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T12:41:03Z","timestamp":1583498463000},"page":"247-254","source":"Crossref","is-referenced-by-count":40,"title":["Lyme disease: diagnosis and treatment"],"prefix":"10.1097","volume":"32","author":[{"given":"Robert T.","family":"Schoen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230829","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.1780200102","article-title":"Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities","volume":"20","author":"Steere","year":"1977","journal-title":"Arthritis Rheum"},{"key":"R2-20230829","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.idc.2015.02.010","article-title":"Epidemiology of Lyme disease","volume":"29","author":"Mead","year":"2015","journal-title":"Infect Dis Clin North Am"},{"key":"R3-20230829","doi-asserted-by":"crossref","first-page":"16090","DOI":"10.1038\/nrdp.2016.90","article-title":"Lyme borreliosis","volume":"2","author":"Steere","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"R4-20230829","first-page":"1","article-title":"Surveillance for Lyme disease--United States, 1992\u20132006","volume":"57","author":"Bacon","year":"2008","journal-title":"MMWR Surveill Summ"},{"key":"R5-20230829","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.7043737","article-title":"Lyme disease-a tick-borne spirochetosis?","volume":"216","author":"Burgdorfer","year":"1982","journal-title":"Science"},{"key":"R6-20230829","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(11)60103-7","article-title":"Lyme borreliosis","volume":"379","author":"Stanek","year":"2012","journal-title":"Lancet"},{"key":"R7-20230829","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ttbdis.2018.10.009","article-title":"Acrodermatitis chronica atrophicans in children: report on two cases and review of the literature","volume":"10","author":"Maraspin","year":"2019","journal-title":"Ticks Tick Borne Dis"},{"key":"R8-20230829","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJM198908313210906","article-title":"Lyme disease","volume":"321","author":"Steere","year":"1989","journal-title":"N Engl J Med"},{"key":"R9-20230829","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1002\/art.22131","article-title":"Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis","volume":"54","author":"Steere","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R10-20230829","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.idc.2015.02.004","article-title":"Diagnosis and treatment of Lyme arthritis","volume":"29","author":"Arvikar","year":"2015","journal-title":"Infect Dis Clin North Am"},{"key":"R11-20230829","doi-asserted-by":"crossref","first-page":"354","DOI":"10.7326\/0003-4819-128-5-199803010-00003","article-title":"The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study","volume":"128","author":"Reid","year":"1998","journal-title":"Ann Intern Med"},{"key":"R12-20230829","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/zph.12307","article-title":"Lyme disease surveillance in New York State: an assessment of case underreporting","volume":"65","author":"White","year":"2018","journal-title":"Zoonoses Public Health"},{"key":"R13-20230829","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/zph.12291","article-title":"Underreporting of Lyme and other tick-borne diseases in residents of a high-incidence county, Minnesota, 2009","volume":"65","author":"Schiffman","year":"2018","journal-title":"Zoonoses Public Health"},{"key":"R14-20230829","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3201\/eid2109.150417","article-title":"Incidence of clinician-diagnosed Lyme disease, United States, 2005\u20132010","volume":"21","author":"Nelson","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"R15-20230829","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/08912963.2014.897699","article-title":"Spirochete-like cells in a Dominican amber Ambylomma tick (Arachnida: Ixodidae)","volume":"27","author":"Poinar","year":"2015","journal-title":"Historical Biol"},{"key":"R16-20230829","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1749-6632.1994.tb19865.x","article-title":"The emergence of Lyme disease and human babesiosis in a changing environment","volume":"740","author":"Spielman","year":"1994","journal-title":"Ann N Y Acad Sci"},{"key":"R17-20230829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6622a1","article-title":"Surveillance for Lyme Disease - United States, 2008\u20132015","volume":"66","author":"Schwartz","year":"2017","journal-title":"MMWR Surveill Summ"},{"key":"R18-20230829","doi-asserted-by":"crossref","first-page":"e0189393","DOI":"10.1371\/journal.pone.0189393","article-title":"Northward range expansion of Ixodes scapularis evident over a short timescale in Ontario, Canada","volume":"12","author":"Clow","year":"2017","journal-title":"PLoS One"},{"key":"R19-20230829","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.vetpar.2008.10.093","article-title":"Prevalence and geographic distribution of Dirofilaria immitis, Borrelia burgdorferi, Ehrlichia canis, and Anaplasma phagocytophilum in dogs in the United States: results of a national clinic-based serologic survey","volume":"160","author":"Bowman","year":"2009","journal-title":"Vet Parasitol"},{"key":"R20-20230829","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.3201\/eid2108.141878","article-title":"Geographic distribution and expansion of human Lyme disease, United States","volume":"21","author":"Kugeler","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"R21-20230829","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.idc.2015.02.001","article-title":"Erythema migrans","volume":"29","author":"Nadelman","year":"2015","journal-title":"Infect Dis Clin North Am"},{"key":"R22-20230829","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.ttbdis.2019.02.015","article-title":"A minority of children diagnosed with Lyme disease recall a preceding tick bite","volume":"10","author":"Nigrovic","year":"2019","journal-title":"Ticks Tick Borne Dis"},{"key":"R23-20230829","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7326\/0003-4819-136-6-200203190-00005","article-title":"Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans","volume":"136","author":"Smith","year":"2002","journal-title":"Ann Intern Med"},{"key":"R24-20230829","doi-asserted-by":"crossref","first-page":"751","DOI":"10.7326\/0003-4819-142-9-200505030-00011","article-title":"Brief communication: hematogenous dissemination in early Lyme disease","volume":"142","author":"Wormser","year":"2005","journal-title":"Ann Intern Med"},{"key":"R25-20230829","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.idc.2015.02.003","article-title":"Lyme carditis","volume":"29","author":"Robinson","year":"2015","journal-title":"Infect Dis Clin North Am"},{"key":"R26-20230829","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1080\/23744235.2016.1193790","article-title":"No serological evidence for Borrelia burgdorferi sensu lato infection in patients with dilated cardiomyopathy in Northern France","volume":"48","author":"N\u2019Guyen","year":"2016","journal-title":"Infect Dis (Lond)"},{"key":"R27-20230829","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.arcped.2019.02.010","article-title":"Lyme neuroborreliosis in children: Report of nine cases and a review of the literature","volume":"26","author":"Guet-Revillet","year":"2019","journal-title":"Arch Pediatr"},{"key":"R28-20230829","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/QCO.0000000000000332","article-title":"Lyme neuroborreliosis","volume":"30","author":"Koedel","year":"2017","journal-title":"Curr Opin Infect Dis"},{"key":"R29-20230829","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1212\/WNL.42.9.1845-m","article-title":"CNS Lyme disease","volume":"42","author":"Pachner","year":"1992","journal-title":"Neurology"},{"key":"R30-20230829","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/QCO.0000000000000545","article-title":"Lyme neuroborreliosis","volume":"32","author":"Halperin","year":"2019","journal-title":"Current opinion in infectious diseases"},{"key":"R31-20230829","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/ene.13197","article-title":"No association between Borrelia burgdorferi antibodies and amyotrophic lateral sclerosis in a case-control study","volume":"24","author":"Visser","year":"2017","journal-title":"Eur J Neurol"},{"key":"R32-20230829","doi-asserted-by":"crossref","first-page":"725","DOI":"10.7326\/0003-4819-107-5-725","article-title":"The clinical evolution of Lyme arthritis","volume":"107","author":"Steere","year":"1987","journal-title":"Ann Intern Med"},{"key":"R33-20230829","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.semarthrit.2018.09.007","article-title":"Characteristics and clinical outcomes after treatment of a national cohort of PCR-positive Lyme arthritis","volume":"48","author":"Grillon","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"R34-20230829","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nrrheum.2010.209","article-title":"A case revealing the natural history of untreated Lyme disease","volume":"7","author":"Schoen","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"R35-20230829","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3899\/jrheum.180775","article-title":"Pediatric antibiotic-refractory Lyme arthritis: a multicenter case-control study","volume":"46","author":"Horton","year":"2019","journal-title":"J Rheumatol"},{"key":"R36-20230829","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/cid\/cix943","article-title":"Advances in serodiagnostic testing for Lyme disease are at hand","volume":"66","author":"Branda","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R37-20230829","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/cid\/ciy614","article-title":"Direct diagnostic tests for Lyme disease","volume":"68","author":"Schutzer","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R38-20230829","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/14737159.2016.1246959","article-title":"Progress in the molecular diagnosis of Lyme disease","volume":"17","author":"Ruzic-Sabljic","year":"2017","journal-title":"Expert Rev Mol Diagn"},{"key":"R39-20230829","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1128\/JCM.03394-15","article-title":"The past, present, and (possible) future of serologic testing for Lyme disease","volume":"54","author":"Theel","year":"2016","journal-title":"J Clin Microbiol"},{"key":"R40-20230829","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.idc.2015.02.005","article-title":"Laboratory diagnosis of Lyme disease: advances and challenges","volume":"29","author":"Marques","year":"2015","journal-title":"Infect Dis Clin North Am"},{"key":"R41-20230829","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cca.2018.01.030","article-title":"Promising alternatives for one-tier testing of Lyme borreliosis","volume":"479","author":"Alasel","year":"2018","journal-title":"Clin Chim Acta"},{"key":"R42-20230829","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/cid\/cit238","article-title":"Editorial commentary: better laboratory testing for Lyme disease: no more western blot","volume":"57","author":"Schoen","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R43-20230829","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.cmi.2019.02.020","article-title":"Lyme disease overdiagnosis in a large healthcare system: a population-based, retrospective study","volume":"25","author":"Webber","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"R44-20230829","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.cmi.2015.08.005","article-title":"Testing patients with nonspecific symptoms for antibodies against Borrelia burgdorferi sensu lato does not provide useful clinical information about their aetiology","volume":"21","author":"Markowicz","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"R45-20230829","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/cid\/civ584","article-title":"Poor positive predictive value of Lyme disease serologic testing in an area of low disease incidence","volume":"61","author":"Lantos","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R46-20230829","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pmedr.2018.11.004","article-title":"Interventions to prevent Lyme disease in humans: A systematic review","volume":"13","author":"Richardson","year":"2019","journal-title":"Prev Med Rep"},{"key":"R47-20230829","article-title":"Protective immunity and new vaccines for Lyme disease","author":"Gomes-Solecki","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R48-20230829","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1056\/NEJM200107123450201","article-title":"Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite","volume":"345","author":"Nadelman","year":"2001","journal-title":"N Engl J Med"},{"key":"R49-20230829","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.diagmicrobio.2018.01.025","article-title":"Is the risk of early neurologic Lyme borreliosis reduced by preferentially treating patients with erythema migrans with doxycycline?","volume":"91","author":"Strle","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R50-20230829","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1001\/jama.2016.6888","article-title":"Treatment of Lyme disease","volume":"315","year":"2016","journal-title":"JAMA"},{"key":"R51-20230829","doi-asserted-by":"crossref","first-page":"e0207067","DOI":"10.1371\/journal.pone.0207067","article-title":"A systematic review on the impact of gestational Lyme disease in humans on the fetus and newborn","volume":"13","author":"Waddell","year":"2018","journal-title":"PLoS One"},{"key":"R52-20230829","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8111857","article-title":"Early lyme borreliosis in patients treated with tumour necrosis factor-alfa inhibitors","volume":"8","author":"Maraspin","year":"2019","journal-title":"J Clin Med"},{"key":"R53-20230829","doi-asserted-by":"crossref","first-page":"ofz292","DOI":"10.1093\/ofid\/ofz292","article-title":"Erythema migrans: course and outcome in patients treated with rituximab","volume":"6","author":"Maraspin","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"R54-20230829","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R55-20230829","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1001\/jama.2016.2884","article-title":"Diagnosis, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: a review","volume":"315","author":"Sanchez","year":"2016","journal-title":"JAMA"},{"key":"R56-20230829","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1128\/AAC.46.11.3637-3640.2002","article-title":"Erythromycin resistance in Borrelia burgdorferi","volume":"46","author":"Terekhova","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"R57-20230829","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/0003-4819-124-9-199605010-00002","article-title":"Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial","volume":"124","author":"Luft","year":"1996","journal-title":"Ann Intern Med"},{"key":"R58-20230829","first-page":"CD006978","article-title":"Antibiotics for the neurological complications of Lyme disease","volume":"12","author":"Cadavid","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"R59-20230829","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/ene.12744","article-title":"Efficacy and safety of pharmacological treatments for acute Lyme neuroborreliosis - a systematic review","volume":"22","author":"Dersch","year":"2015","journal-title":"Eur J Neurol"},{"key":"R60-20230829","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S1474-4422(08)70119-4","article-title":"Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, noninferiority, double-blind, randomised trial","volume":"7","author":"Ljostad","year":"2008","journal-title":"Lancet Neurol"},{"key":"R61-20230829","first-page":"993","article-title":"Three sudden cardiac deaths associated with Lyme carditis - United States, November 2012-July 2013","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R63-20230829","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(88)92011-9","article-title":"Treatment of late Lyme borreliosis--randomised comparison of ceftriaxone and penicillin","volume":"1","author":"Dattwyler","year":"1988","journal-title":"Lancet"},{"key":"R64-20230829","first-page":"2025","article-title":"Lyme arthritis in children and adolescents: outcome 12 months after initiation of antibiotic therapy","volume":"27","author":"Bentas","year":"2000","journal-title":"J Rheumatol"},{"key":"R65-20230829","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.diagmicrobio.2018.03.016","article-title":"Outcome of facial palsy from Lyme disease in prospectively followed patients who had received corticosteroids","volume":"91","author":"Wormser","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R66-20230829","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/lary.26273","article-title":"Steroid use in Lyme disease-associated facial palsy is associated with worse long-term outcomes","volume":"127","author":"Jowett","year":"2017","journal-title":"Laryngoscope"},{"key":"R67-20230829","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00296-013-2923-9","article-title":"Intraarticular corticosteroids in refractory childhood Lyme arthritis","volume":"34","author":"Nimmrich","year":"2014","journal-title":"Rheumatol Int"},{"key":"R68-20230829","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3899\/jrheum.180829","article-title":"Intraarticular glucocorticoid injection as second-line treatment for Lyme arthritis in children","volume":"46","author":"Horton","year":"2019","journal-title":"J Rheumatol"},{"key":"R69-20230829","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/art.40039","article-title":"MicroRNA expression shows inflammatory dysregulation and tumor-like proliferative responses in joints of patients with postinfectious Lyme arthritis","volume":"69","author":"Lochhead","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"R70-20230829","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/art.1780340817","article-title":"Treatment of refractory chronic Lyme arthritis with arthroscopic synovectomy","volume":"34","author":"Schoen","year":"1991","journal-title":"Arthritis Rheum"},{"key":"R71-20230829","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/cid\/civ277","article-title":"Long-term assessment of health-related quality of life in patients with culture-confirmed early Lyme disease","volume":"61","author":"Wormser","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R72-20230829","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.amjmed.2014.09.022","article-title":"Long-term assessment of fatigue in patients with culture-confirmed Lyme disease","volume":"128","author":"Wormser","year":"2015","journal-title":"The American journal of medicine"},{"key":"R73-20230829","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/art.38972","article-title":"Long-term assessment of fibromyalgia in patients with culture-confirmed Lyme disease","volume":"67","author":"Wormser","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R74-20230829","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.idc.2015.02.012","article-title":"Posttreatment Lyme disease syndrome","volume":"29","author":"Aucott","year":"2015","journal-title":"Infect Dis Clin North Am"},{"key":"R75-20230829","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fmed.2017.00224","article-title":"The clinical, symptom, and quality-of-life characterization of a well defined group of patients with posttreatment Lyme disease syndrome","volume":"4","author":"Rebman","year":"2017","journal-title":"Front Med"},{"key":"R76-20230829","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/s12889-019-6681-9","article-title":"Estimation of cumulative number of posttreatment Lyme disease cases in the US, 2016 and 2020","volume":"19","author":"DeLong","year":"2019","journal-title":"BMC Public Health"},{"key":"R77-20230829","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.idc.2015.02.006","article-title":"Chronic Lyme disease","volume":"29","author":"Lantos","year":"2015","journal-title":"Infect Dis Clin North Am"},{"key":"R78-20230829","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa1505425","article-title":"Randomized trial of longer-term therapy for symptoms attributed to Lyme disease","volume":"374","author":"Berende","year":"2016","journal-title":"N Engl J Med"},{"key":"R79-20230829","doi-asserted-by":"crossref","first-page":"e1447","DOI":"10.1212\/WNL.0000000000007186","article-title":"Effect of prolonged antibiotic treatment on cognition in patients with Lyme borreliosis","volume":"92","author":"Berende","year":"2019","journal-title":"Neurology"},{"key":"R80-20230829","doi-asserted-by":"crossref","first-page":"607","DOI":"10.15585\/mmwr.mm6623a3","article-title":"Serious bacterial infections acquired during treatment of patients given a diagnosis of chronic Lyme disease - United States","volume":"66","author":"Marzec","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R81-20230829","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/17843286.2016.1180829","article-title":"Ceftriaxone-induced immune hemolytic anemia as a life-threatening complication of antibiotic treatment of \u2019chronic Lyme disease\u2019","volume":"72","author":"De Wilde","year":"2017","journal-title":"Acta clinica Belgica"},{"key":"R82-20230829","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1093\/cid\/civ186","article-title":"Unorthodox alternative therapies marketed to treat Lyme disease","volume":"60","author":"Lantos","year":"2015","journal-title":"Clin Infect Dis"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000698","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T07:12:28Z","timestamp":1693293148000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":81,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000698","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}